Literature DB >> 14563495

Fangchinoline inhibits rat aortic vascular smooth muscle cell proliferation and cell cycle progression through inhibition of ERK1/2 activation and c-fos expression.

Yong-He Zhang1, Lian-Hua Fang, Bao-Shan Ku.   

Abstract

Fangchinoline (FAN; a plant alkaloid isolated from Stephania tetrandrae) is a nonspecific Ca(2+) channel blocker. The objective of the present study was to investigate the effect of FAN on the growth factor-induced proliferation of primary cultured rat aortic smooth muscle cells (RASMCs). FAN significantly inhibited both 5% fetal bovine serum (FBS)- and 50ng/mL platelet-derived growth factor (PDGF)-BB-induced proliferation, [3H]thymidine incorporation into DNA and phosphorylation of extracellular signal-regulated kinase 1/2. In accordance with these findings, FAN revealed blocking of the FBS-inducible progression through G(0)/G(1) to S phase of the cell cycle in synchronized cells and caused a 62% decrease in the early elevation of c-fos expression induced after 5% FBS addition. Furthermore, significant antiproliferative activity of FAN is observed at concentrations below those required to achieve significant inhibition of Ca(2+) channels by FAN. These results suggest that FAN reduced both FBS- and PDGF-BB-induced RASMCs proliferation by perturbing cell cycle progression. This antiproliferative effect of FAN is dependent on the MAP kinase pathway, but cannot be limited to its Ca(2+) modulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563495     DOI: 10.1016/s0006-2952(03)00550-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells.

Authors:  Ning Wang; Weidong Pan; Meifen Zhu; Maosheng Zhang; Xiaojian Hao; Guangyi Liang; Yibin Feng
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  Fangchinoline inhibits the proliferation of SPC-A-1 lung cancer cells by blocking cell cycle progression.

Authors:  Xue Luo; Jian-Ming Peng; Lan-DI Su; Dong-Yan Wang; You-Jiang Yu
Journal:  Exp Ther Med       Date:  2015-12-04       Impact factor: 2.447

3.  Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury.

Authors:  Kae-Woei Liang; Chih-Tai Ting; Sui-Chu Yin; Ying-Tsung Chen; Shing-Jong Lin; James K Liao; Shih-Lan Hsu
Journal:  Biochem Pharmacol       Date:  2006-01-31       Impact factor: 5.858

4.  Fangchinoline suppresses the growth and invasion of human glioblastoma cells by inhibiting the kinase activity of Akt and Akt-mediated signaling cascades.

Authors:  Bingyu Guo; Peng Xie; Jingyuan Su; Tingting Zhang; Xiaoming Li; Guobiao Liang
Journal:  Tumour Biol       Date:  2015-09-25

5.  Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.

Authors:  Feng Tian; Ding Ding; Dandan Li
Journal:  Int J Oncol       Date:  2015-04-09       Impact factor: 5.650

6.  Effect of fangchinoline on root resorption during rat orthodontic tooth movement.

Authors:  Xingfu Bao; Min Hu; Yi Zhang; Ferdinand Machibya; Ying Zhang; Huan Jiang; Dongsheng Yu
Journal:  Korean J Orthod       Date:  2012-06-28       Impact factor: 1.372

7.  Pitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMC.

Authors:  Yu Mi Ha; Ju-Ock Nam; Young Jin Kang
Journal:  Korean J Physiol Pharmacol       Date:  2015-10-16       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.